Androgen Receptors in Human Breast Cancer and Female Canine Mammary Tumors
Molecules,
Journal Year:
2025,
Volume and Issue:
30(7), P. 1411 - 1411
Published: March 22, 2025
This
review
explores
the
potential
role
of
androgens
in
human
breast
cancer
and
female
canine
mammary
tumors.
Human
is
one
most
common
cancers
affecting
women
globally,
while
tumors
provide
a
natural
model
for
study
due
to
their
similar
histopathologies
molecular
features.
Androgen
receptors,
typically
linked
male
sex
hormones,
are
present
up
90%
These
receptors
interact
with
estrogen-receptor
signaling,
suggesting
involvement
complex
mechanism
progression.
have
become
key
players
biology,
offering
new
targets
therapeutic
strategies.
The
presence
these
both
raises
important
questions
about
development
malignancies.
While
exact
mechanisms
remain
be
fully
elucidated,
research
suggests
that
targeting
androgen-receptor
signaling
could
novel
approach
humans
canines.
Further
studies
necessary
understand
implications
expression
develop
more
effective
targeted
therapies
cancers.
Language: Английский
The Number and Size of Invasion Areas in Mixed-Type Carcinoma in Female Dogs Are Associated with Regional Metastases
Veterinary Sciences,
Journal Year:
2025,
Volume and Issue:
12(4), P. 318 - 318
Published: March 31, 2025
Mixed-type
carcinoma
(MTC)
accounts
for
44%
of
mammary
neoplasms
in
bitches
and
poses
challenges
histological
grading
due
to
the
heterogeneity
invasive
areas.
The
present
study
aimed
measure
characterize
areas
stroma
MTC
investigate
association
those
parameters
with
lymph
node
status
survival.
Forty
cases
were
analyzed
divided
into
two
groups:
metastasis
without
metastasis.
size,
perimeter,
length,
number
carcinomatous
measured.
Cases
showed
a
higher
foci
(p
=
0.003)
larger
0.006)
compared
Bitches
than
2
mm2
had
shorter
survival
times.
No
was
found
between
perimeter
or
length
areas,
expression
Ki67,
ER,
PR,
COX-2,
HER-2,
immunophenotype.
Thus,
size
are
associated
regional
status,
suggesting
histomorphometry
may
serve
as
valuable
tool
evaluating
biological
behavior
mixed-type
carcinoma.
Language: Английский
Transcriptomic profiling of miRNA-mRNA interactions in canine oocytes and cumulus cells during in vitro maturation: a sequencing analysis
Phillip Dettleff,
No information about this author
Jaime Palomino,
No information about this author
Fabiola González-Coppia
No information about this author
et al.
Theriogenology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 117454 - 117454
Published: April 1, 2025
Language: Английский
Age at Tumor Diagnosis in 14,636 Canine Cases from the Pathology-Based UNIPI Animal Cancer Registry, Italy: One Size Doesn’t Fit All
Veterinary Sciences,
Journal Year:
2024,
Volume and Issue:
11(10), P. 485 - 485
Published: Oct. 8, 2024
Cancer
is
the
most
common
cause
of
death
in
adult
dogs.
All
dogs
would
benefit
from
early
diagnosis,
but
there
are
no
specific
guidelines
regarding
schedule
cancer
screening
companion
animals.
The
aim
this
study
was
to
retrospectively
evaluate
age
at
diagnosis
Italian
oncological
canine
patients.
A
total
14,636
histologically
confirmed
neoplastic
cases
were
coded
according
Vet-ICD-O-canine-1
and
stratified
by
malignancy,
sex,
neutering
status,
breed,
cephalic
index,
body
size,
tumor
type.
Differences
distribution
analyzed
influence
these
variables
on
time
first
malignancy
assessed
using
an
event
history
analysis
model.
median
for
benign
malignant
tumors
9
10
years,
respectively.
Intact
purebred
diagnosed
earlier,
differed
significantly
breed.
earliest
recorded
lymphomas
mast
cell
tumors.
model
showed
accelerating
effect
large
brachy-
dolichocephaly,
sexual
integrity
female
diagnosis.
Our
results
confirm
that
a
"one-size-fits-all"
approach
not
accurate
provide
relevant
data
may
lead
establishment
breed-based
schedules.
Language: Английский
Role of miRNAs in breast cancer development and progression: Current research
Sachin Kumar,
No information about this author
Abhishek Ranga
No information about this author
BioFactors,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 27, 2024
Breast
cancer,
a
complex
and
heterogeneous
ailment
impacting
numerous
women
worldwide,
persists
as
prominent
cause
of
cancer-related
fatalities.
MicroRNAs
(miRNAs),
small
non-coding
RNAs,
have
garnered
significant
attention
for
their
involvement
in
breast
cancer's
progression.
These
molecules
post-transcriptionally
regulate
gene
expression,
influencing
crucial
cellular
processes
including
proliferation,
differentiation,
apoptosis.
This
review
provides
an
overview
the
current
research
on
role
miRNAs
cancer.
It
discusses
different
subtypes
molecular
characteristics,
mechanisms
by
which
expression
cancer
cells.
Additionally,
highlights
recent
studies
identifying
specific
that
are
dysregulated
potential
use
diagnostic
prognostic
biomarkers.
Furthermore,
explores
therapeutic
treatment.
Preclinical
shown
effectiveness
miRNA-based
therapies,
such
antagomir
miRNA
mimic
inhibiting
tumor
growth
metastasis.
Emerging
areas,
application
artificial
intelligence
(AI)
to
advance
"One
Health"
approach
integrates
human
animal
insights,
also
discussed.
However,
challenges
remain
before
these
therapies
can
be
fully
translated
into
clinical
practice.
In
conclusion,
this
emphasizes
significance
innovative
tools.
A
deeper
understanding
dysregulation
is
essential
successful
settings.
With
continued
research,
approaches
hold
promise
improving
patient
outcomes
devastating
disease.
Language: Английский
Let-7b, miR-29b, and miR-125b as Potential Biomarkers for Differentiating Canine Mammary Carcinoma Histological Types
Animals,
Journal Year:
2024,
Volume and Issue:
15(1), P. 20 - 20
Published: Dec. 25, 2024
Epigenetics
is
the
study
of
changes
in
organisms
that
result
from
modifications
gene
expression
rather
than
alterations
genetic
code
itself
[...]
Language: Английский